Associate Professor, Neurology, UCLA School of Medicine
Neurology
Dr. John M. Ringman, MD
|
|
Give Review
John M. Ringman works in the field of Neurology. He attended Baylor College of Medicine. John Ringman is a published doctor and has 94 publications published. The lastest was: 'Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.' John Ringman is registered with Medicare and accepts Medicare payments.
Publications
- Early behavioural changes in familial Alzheimer's Disease in the Dominantly Inherited Alzheimer Network.
- Factors associated with the onset and persistence of post-lumbar puncture Headache.
- A Multiancestral Genome-Wide Exome Array Study of Alzheimer Disease, Frontotemporal Dementia, and Progressive Supranuclear Palsy.
- Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study.
- Genetic heterogeneity in Alzheimer Disease and implications for treatment strategies.
- Effect of Potent γ-Secretase Modulator in Human Neurons Derived From Multiple Presenilin 1-Induced Pluripotent Stem Cell Mutant Carriers.
- Functional connectivity in autosomal dominant and late-onset Alzheimer Disease.
- Symptom onset in autosomal dominant Alzheimer Disease: A systematic review and meta-analysis.
- Age effects on cortical thickness in cognitively normal elderly individuals.
- Clinical Predictors of Severe Cerebral Amyloid Angiopathy and Influence of APOE Genotype in Persons With Pathologically Verified Alzheimer Disease.
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease.
- The "Alzheimer's Type" Profile of Semantic Clustering in Amnestic Mild Cognitive Impairment.
- A Novel PSEN1 Mutation (I238M) associated with Early-Onset Alzheimer's Disease in an African-American Woman.
- Younger age of Dementia diagnosis in a Hispanic population in southern California.
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer's Disease.
- Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial.
- Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: Comparison with 15o-water positron ...
- The pattern of atrophy in familial Alzheimer Disease: Volumetric MRI results from the DIAN study.
- Similar verbal fluency patterns in amnestic mild cognitive impairment and Alzheimer's Disease.
- Impaired default network functional connectivity in autosomal dominant Alzheimer Disease.
- The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's Disease.
- Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults.
- Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
- 1?,25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-? Phagocytosis and Inflammation in Alzheimer's Disease Patients.
- Complexity and synchronicity of resting state blood oxygenation level-dependent (BOLD) functional MRI in normal aging and cognitive decline.
- Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's Disease mutations.
- Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's Disease.
- Memory performance and fMRI signal in presymptomatic familial Alzheimer's Disease.
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's Diseases.
- Plasma Methionine Sulfoxide in Persons with Familial Alzheimer's Disease Mutations.
- Relationship of a Variant in the NTRK1 Gene to White Matter Microstructure in Young Adults.
- Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.
- Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer Disease mutations.
- Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer's Disease.
- Should persons with autosomal dominant AD be included in clinical trials?
- Common Alzheimer's Disease Risk Variant Within the CLU Gene Affects White Matter Microstructure in Young Adults.
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's Disease.
- Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's Disease mutations during a novelty encoding task.
- Autosomal-dominant Alzheimer's Disease: a review and proposal for the prevention of Alzheimer's Disease.
- An update on the diagnosis and management of dementing conditions.
- Increased fMRI signal with age in familial Alzheimer's Disease mutation carriers.
- The use of profanity during letter fluency tasks in frontotemporal dementia and Alzheimer Disease.
- Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer Disease cerebrospinal fluid.
- Commentary on "a roadmap for the prevention of Dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheime...
- Mosaicism for trisomy 21 in a patient with young-onset Dementia: a case report and brief literature review.
- Children of persons with Alzheimer Disease: what does the future hold?
- The Huntington Disease of woody guthrie: another man done gone.
- Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's Disease patients are improved by bisdemethoxycurcumin.
- An experimental approach to detecting dementia in Down syndrome: a paradigm for Alzheimer's Disease.
- Performance on MMSE sub-items and education level in presenilin-1 mutation carriers without Dementia.
- Serendipitous improvement in the Yips associated with memantine use.
- Visualizing language deterioration in progressive aphasias.
- The A431E mutation in PSEN1 causing familial Alzheimer's Disease originating in Jalisco State, Mexico: an additional fifteen families.
- The Thr354Ile substitution in PSEN1:: Disease-causing mutation or polymorphism?
- What the study of persons at risk for familial Alzheimer's Disease can tell us about the earliest stages of the disorder: a review.
- Earlier Alzheimer onset in Latino persons: ethnic difference vs selection bias.
- Carbonic anhydrase inhibitors and amobarbital resistance.
- Mitochondrial encephalomyopathy with lactic acidosis and Stroke (MELAS).
- Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA.
- The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's Disease in Mexico.
- Neuropathologic correlates of trial-related instruments for Alzheimer's Disease.
- Family history of dementia in early-onset versus very late-onset Alzheimer''s Disease.
- Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer''s Disease patients.
- Mary S. Easton Center of Alzheimer''s Disease Research at UCLA: advancing the therapeutic imperative.
- Hemispheric asymmetry of gaze deviation and relationship to neglect in acute Stroke.
- Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation.
- Cortical event-related potentials in preclinical familial Alzheimer Disease.
- Biochemical markers in persons with preclinical familial Alzheimer Disease.
- Treatment of REM sleep behavior disorder with donepezil: a report of three cases.
- Occurrence of tics in Asperger's syndrome and autistic disorder.
- Pedophilia and temporal lobe disturbances.
- Metrifonate: update on a new antiDementia agent.
- An African American family with early-onset Alzheimer Disease and an APP (T714I) mutation.
- Frequency, risk factors, anatomy, and course of unilateral neglect in an acute Stroke cohort.
- Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin.
- Neuropsychological function in nondemented carriers of presenilin-1 mutations.
- Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer''s Disease.
- A potential role of the curry spice curcumin in Alzheimer''s Disease.
- Current and emerging pharmacological treatment options for Dementia.
- Donepezil improves cognitive function and reduces decline in activities of daily living in people with severe Alzheimer''s Disease.
- Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer''s Disease mutations.
- Myopathy associated with chronic orlistat consumption: a case report.
- Increased prevalence of significant recurrent headache in preclinical familial Alzheimer''s Disease mutation carriers.
- Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer''s Disease.
- Neuroimaging measures as endophenotypes in Alzheimer''s Disease.
- Setting the stage for prevention of familial Alzheimer''s Disease.
- Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer''s Disease.
- Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer''s Disease.
- Diagnosing depression in Alzheimer Disease with the national institute of mental health provisional criteria.
- Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer''s Disease due to a novel PSEN1 mutation.
- Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer''s Disease.
- Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.
Schools
McGill University Faculty Of Medicine
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Brain Aneurysm
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Baylor College of Medicine -
McGill University Faculty of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1265451173 | |
| NPPES Provider LastName | RINGMAN | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 387.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265451173 |
| Last Name Of The Provider | RINGMAN |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Annette M. Langer, MD |
|
|
Dr. Shaun A. Hussain, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Indu Subramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin C. Brennan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Giselle Petzinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Green, MD |
|
|
Dr. Richard A. Graham, MD |
|
|
Dr. Michael E. Mahler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence M. Richman, MD |
|
Dr. Leon Barkodar, MD |
|
|
Dr. Collins Y. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Shaner, MD
This Doctor is OpenDoctor Recommended.
|